Hiroshi Furuse

642 total citations
42 papers, 442 citations indexed

About

Hiroshi Furuse is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Hiroshi Furuse has authored 42 papers receiving a total of 442 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Surgery, 22 papers in Pulmonary and Respiratory Medicine and 10 papers in Oncology. Recurrent topics in Hiroshi Furuse's work include Renal cell carcinoma treatment (10 papers), Bladder and Urothelial Cancer Treatments (10 papers) and Urinary Bladder and Prostate Research (6 papers). Hiroshi Furuse is often cited by papers focused on Renal cell carcinoma treatment (10 papers), Bladder and Urothelial Cancer Treatments (10 papers) and Urinary Bladder and Prostate Research (6 papers). Hiroshi Furuse collaborates with scholars based in Japan. Hiroshi Furuse's co-authors include Seiichiro Ozono, Soichi Mugiya, Takayuki Sugiyama, Atsushi Otsuka, Taro Shuin, Keiji Inoue, Masafumi Oyama, Kiyohide Fujimoto, Hideyasu Matsuyama and Hideaki Miyake and has published in prestigious journals such as PLoS ONE, The Journal of Urology and Urology.

In The Last Decade

Hiroshi Furuse

38 papers receiving 434 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hiroshi Furuse Japan 12 213 195 111 65 62 42 442
Marita Laurila Finland 13 228 1.1× 130 0.7× 44 0.4× 81 1.2× 34 0.5× 22 489
Francisco R. Rodriguez United States 10 165 0.8× 187 1.0× 59 0.5× 75 1.2× 82 1.3× 18 447
Levent N. Türkeri Türkiye 11 159 0.7× 227 1.2× 131 1.2× 86 1.3× 36 0.6× 37 428
Yusuke Sato Japan 12 138 0.6× 137 0.7× 143 1.3× 51 0.8× 18 0.3× 57 427
Jingfei Teng China 12 296 1.4× 75 0.4× 273 2.5× 134 2.1× 37 0.6× 28 491
Dharam Ramnani United States 9 174 0.8× 141 0.7× 43 0.4× 47 0.7× 11 0.2× 12 377
Ja Yoon Ku South Korea 13 139 0.7× 190 1.0× 57 0.5× 115 1.8× 7 0.1× 49 438
Toru Nishiyama Japan 12 238 1.1× 160 0.8× 27 0.2× 53 0.8× 15 0.2× 42 468
Veronica Papavero United States 10 189 0.9× 202 1.0× 50 0.5× 169 2.6× 35 0.6× 12 583
Se Joong Kim South Korea 13 257 1.2× 66 0.3× 87 0.8× 103 1.6× 15 0.2× 43 444

Countries citing papers authored by Hiroshi Furuse

Since Specialization
Citations

This map shows the geographic impact of Hiroshi Furuse's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroshi Furuse with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroshi Furuse more than expected).

Fields of papers citing papers by Hiroshi Furuse

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hiroshi Furuse. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroshi Furuse. The network helps show where Hiroshi Furuse may publish in the future.

Co-authorship network of co-authors of Hiroshi Furuse

This figure shows the co-authorship network connecting the top 25 collaborators of Hiroshi Furuse. A scholar is included among the top collaborators of Hiroshi Furuse based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hiroshi Furuse. Hiroshi Furuse is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kitagawa, Yuko, Hiroki Tanaka, Eiji Suzuki, et al.. (2024). Risk Classification of Patients With Advanced Urothelial Carcinoma Treated With Enfortumab Vedotin. Cancer Diagnosis & Prognosis. 4(6). 783–788. 2 indexed citations
2.
3.
Matsushita, Yuto, et al.. (2018). Marked response to nivolumab combined with external radiation therapy for metastatic renal cell carcinoma: report of two cases. International Cancer Conference Journal. 8(1). 29–32. 9 indexed citations
4.
5.
6.
Ohashi, Naro, Shinsuke Isobe, Sayaka Ishigaki, et al.. (2016). Plasma Soluble (Pro)renin Receptor Reflects Renal Damage. PLoS ONE. 11(5). e0156165–e0156165. 16 indexed citations
7.
Takayama, Tatsuya, Hiroshi Furuse, Fumitake Kai, Takayuki Sugiyama, & Seiichiro Ozono. (2013). Temsirolimus controlled metastatic advanced renal cell carcinoma for over 4 years: a case study. Medical Oncology. 30(2). 563–563. 3 indexed citations
8.
Tamura, Keita, Hiroshi Furuse, Takayuki Sugiyama, et al.. (2013). BILATERAL ADRENAL HEMORRHAGE DUE TO ADRENAL METASTASIS OF LUNG CANCER. The Japanese Journal of Urology. 104(1). 17–21. 2 indexed citations
9.
Ito, Toshiki, Yutaka KURITA, Hitoshi Shinbo, et al.. (2012). Successful treatment for adrenocorticotropic hormone-independent macronodular adrenal hyperplasia with laparoscopic adrenalectomy: a case series. Journal of Medical Case Reports. 6(1). 312–312. 8 indexed citations
10.
Ito, Toshiki, Yutaka KURITA, Hitoshi Shinbo, et al.. (2012). A CLINICAL STUDY OF LAPAROSCOPIC ADRENALECTOMY FOR PHEOCHROMOCYTOMA -ANALYSIS OF CLINICAL PARAMETERS INFLUENCING OPERATIVE TIME AND INTRAOPERATIVE SYSTOLIC BLOOD PRESSURE. The Japanese Journal of Urology. 103(5). 655–659. 3 indexed citations
11.
Takayama, Tatsuya, Takashi Sugiyama, Fumitake Kai, et al.. (2011). Should Ipsilateral Solitary Adrenal Involvement in Renal Cell Carcinoma be Staged as M1?. Japanese Journal of Clinical Oncology. 41(6). 792–796.
12.
Takayama, Tatsuya, Takayuki Sugiyama, Fumitake Kai, et al.. (2011). Characteristics of aggressive variants in T1a renal cell carcinoma. Journal of Cancer Research and Clinical Oncology. 137(11). 1653–1659. 12 indexed citations
13.
Hamada, Shota, Shiro Hinotsu, Katsuhito Hori, et al.. (2011). The cost of antiemetic therapy for chemotherapy-induced nausea and vomiting in patients receiving platinum-containing regimens in daily practice in Japan: a retrospective study. Supportive Care in Cancer. 20(4). 813–820. 8 indexed citations
14.
Shinbo, Hitoshi, Yutaka KURITA, Takeshi Imanishi, et al.. (2010). Resistive Index as Risk Factor for Acute Urinary Retention in Patients With Benign Prostatic Hyperplasia. Urology. 76(6). 1440–1445. 21 indexed citations
15.
Liu, Hongming, Tatsuya Takayama, Hiroshi Ogawa, et al.. (2009). Impact of Thymidine Phosphorylase-Expressing Macrophages for Surgical Margin in Partial Nephrectomy. Urologia Internationalis. 82(4). 388–393. 2 indexed citations
16.
Shinbo, Hitoshi, Yutaka KURITA, Takeshi Imanishi, et al.. (2009). Resistive Index: A Newly Identified Predictor of Outcome of Transurethral Prostatectomy in Patients With Benign Prostatic Hyperplasia. Urology. 75(1). 143–147. 20 indexed citations
17.
Takayama, Tatsuya, Kazuo Suzuki, Atsushi Otsuka, et al.. (2007). BK virus subtype IV nephropathy occurring 5 years after kidney transplantation. Clinical and Experimental Nephrology. 11(1). 102–106. 2 indexed citations
18.
Takayama, Tatsuya, Soichi Mugiya, Takayuki Sugiyama, et al.. (2006). High Levels of Thymidine Phosphorylase as an Independent Prognostic Factor in Renal Cell Carcinoma. Japanese Journal of Clinical Oncology. 36(9). 564–569. 20 indexed citations
19.
Hirano, Yasuhiro, Kazuo Suzuki, Kimio Fujita, et al.. (2002). Primary signet ring cell carcinoma of the urinary bladder successfully treated with intra-arterial chemotherapy alone. Urology. 59(4). 601–601. 18 indexed citations
20.
Masuda, Hiroaki, et al.. (1995). LOCALIZED AMYLOIDOSIS OF THE PROSTATE : A CASE REPORT. 57(11). 1227–1229.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Marita Laurila Breakdown of academic impact, for papers by Francisco R. Rodriguez Breakdown of academic impact, for papers by Levent N. Türkeri Breakdown of academic impact, for papers by Yusuke Sato Breakdown of academic impact, for papers by Jingfei Teng Breakdown of academic impact, for papers by Dharam Ramnani Breakdown of academic impact, for papers by Ja Yoon Ku Breakdown of academic impact, for papers by Toru Nishiyama Breakdown of academic impact, for papers by Veronica Papavero Breakdown of academic impact, for papers by Se Joong Kim
Rankless by CCL
2026